1-2 of 2
Noriyuki Masuda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

Taroh Satoh, Isamu Okamoto, Masaki Miyazaki, Ryotaroh Morinaga, Asuka Tsuya, Yoshikazu Hasegawa, Masaaki Terashima, Shinya Ueda, Masahiro Fukuoka, Yutaka Ariyoshi, Toshikazu Saito, Noriyuki Masuda, Hirokazu Watanabe, Tetsuo Taguchi, Toru Kakihara, Yumiko Aoyama, Yohko Hashimoto, Kazuhiko Nakagawa
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (11): 3872–3880.
https://doi.org/10.1158/1078-0432.CCR-08-1946
Published: 01 June 2009
View articletitled, Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors in another window
Journal Articles

Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule

Noriyuki Masuda, Kaoru Matsui, Nobuyuki Yamamoto, Toshiji Nogami, Kazuhiko Nakagawa, Shunichi Negoro, Kouji Takeda, Nobuhide Takifuji, Masaji Yamada, Shinzoh Kudoh, Teruyoshi Okuda, Shinjiroh Nemoto, Kanako Ogawa, Hiroshi Myobudani, Shinichi Nihira, Masahiro Fukuoka
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2288–2294.
Published: 01 June 2000
View articletitled, Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule
Open the PDF for Phase I Trial of Oral 2′-Deoxy-2′-methylidenecytidine: On a Daily × 14-day Schedule in another window